Aratana signs $37M licensing deal for pet cancer products By: Kansas City Business Journal via Business Journals March 20, 2014 at 13:20 PM EDT Aratana Therapeutics Inc. announced it has acquired the licensing rights to four products from Advaxis Inc... Read More >>